Funding Opportunities

Engineering Durable HIV Vaccine Responses (ENDURE) (R01 Clinical Trial Not Allowed)

RFA-AI-24-025

NIH

Letter of Intent Deadline: Sep 09 2024

Engineering Durable HIV Vaccine Responses (ENDURE) (R01 Clinical Trial Not Allowed)

Funding Opportunity Purpose

The purpose of this Notice of Funding Opportunity (NOFO) is to support basic and applied research to understand and improve durable immune responses to candidate HIV vaccines.

Learn More